{"canonical":"https://abierto.us/opportunities/75n95024q00396","key":"75N95024Q00396","url":"https://abierto.us/opportunities/75n95024q00396","title":"Analysis of the cerebral spinal fluid and plasma proteome in Alzheimer’s disease","solicitation_number":"75N95024Q00396","notice_type":"k","open":false,"response_deadline":"2024-08-29T20:00:00Z","first_posted":"2024-07-10","last_posted":"2024-08-15","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"NATIONAL INSTITUTES OF HEALTH","office":"NATIONAL INSTITUTES OF HEALTH NIA","naics":"621511","psc":"B537","set_aside":null,"place_state":"MD","place_county":"24510","place_county_name":"City of Baltimore","place_city":"2404000","place_city_name":"Baltimore","winner":"ALAMAR BIOSCIENCES, INC.","award_amount":null,"publications":[{"notice_id":"14ca4bedb5ce4e74a870e3e67cc11a4c","title":"Analysis of the cerebral spinal fluid and plasma proteome in Alzheimer’s disease","solicitation_number":"75N95024Q00396","notice_type":"r","base_type":"r","posted":"2024-07-10","posted_at":null,"due_at":"2024-07-24T13:00:00Z","due_date":"2024-07-24","cancelled":null,"archived":null,"archive_date":"2024-08-08","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/14ca4bedb5ce4e74a870e3e67cc11a4c/view","enriched":false,"history":[]},{"notice_id":"42cc4fe2be2f4310baf8d595025ede3c","title":"Analysis of the cerebral spinal fluid and plasma proteome in Alzheimer’s disease","solicitation_number":"75N95024Q00396","notice_type":"k","base_type":"k","posted":"2024-08-15","posted_at":null,"due_at":"2024-08-29T20:00:00Z","due_date":"2024-08-29","cancelled":null,"archived":null,"archive_date":"2024-09-13","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/42cc4fe2be2f4310baf8d595025ede3c/view","enriched":false,"history":[]}],"latest_notice_id":"42cc4fe2be2f4310baf8d595025ede3c","first_type":"r","notices":[{"dates":{"posted":"2024-07-10","response_deadline":{"raw":"2024-07-24T09:00:00-04:00","utc":"2024-07-24T13:00:00Z","date":"2024-07-24","time":"09:00:00","utc_offset_seconds":-14400}},"links":{"sam":"https://sam.gov/workspace/contract/opp/14ca4bedb5ce4e74a870e3e67cc11a4c/view"},"naics":{"codes":["621511"],"primary":"621511"},"title":"Analysis of the cerebral spinal fluid and plasma proteome in Alzheimer’s disease","agency":{"office":{"code":"75N950","name":"NATIONAL INSTITUTES OF HEALTH NIDA"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-08-08","archive_type":"auto15"},"contacts":[{"name":"Eric McKay","role":"primary","email":"eric.mckay@nih.gov"}],"base_type":{"code":"r","label":"Sources Sought"},"notice_id":"14ca4bedb5ce4e74a870e3e67cc11a4c","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"c7e359d403b36d75d247f02a2ebeb77f4b01eac233d1f5658a1a08c3992bbe42","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Background: Despite the rapid growth of plasma proteomic approaches in neuroscience research, it remains unclear the extent which the level of specific proteins, as measured in blood, relate to levels of the same proteins measured in the central nervous system (CNS), i.e., in cerebral spinal fluid (CSF). Furthermore, it is not known to what extent age and disease status affect these protein-protein relationships. Here, the National Institute on Aging (NIA) intends to take advantage of a unique opportunity to conduct a proteome-wide analysis in a set of participants with available blood and CSF specimens derived from the same visit. Specifically, this requirement will use CSF and plasma specimens from patients seen in the John Hopkins Neurology service collected by Dr. Abhay Moghekar to examine the relationship between corresponding proteins in blood and CSF, i.e., within the central nervous system. Specifically, NIA will apply large-scale proteomics and a multiplexed panel of targeted CNS biomarkers to plasma and CSF specimens to identify participants with Alzheimer’s disease, determine disease stage, and quantify the correlation between 7000 proteins measured within and outside the central nervous system. Additionally, NIA will examine how age (young/middle/older age) and disease status (cognitively normal/Alzheimer’s disease) affect the relationship between corresponding proteins measured in CSF and blood. Purpose and Objectives: The purpose of this requirement is to apply a multiplexed assay of targeted biomarkers for central nervous system (CNS) disease to archived cerebral spinal fluid (CSF) and plasma specimens of participants with Alzheimer’s disease, and healthy young, middle-aged, and older adults. The contract will examine how the relationship between plasma and CSF levels of the same protein correspond to each other across each of these three participant groups. It will also examine the association of plasma and CSF protein levels with measures of cognition and clinical status (e.g., cognitively normal vs. dementia). Targeted biomarkers measured in this element of the project will be used to classify and stage individuals with Alzheimer’s disease. Project requirements: Contractor shall perform the NULISAseq CNS Disease Panel 120 on n=1118 plasma samples (20ul) provided to the contractor by NIA. In addition to providing the NULISA assay, the contractor must perform NGS sequencing to run the assay and provide bioinformatic support. To perform the assay the contractor must use the NULISA™ Platform, which allows for proteomic analysis with attomolar sensitivity. Anticipated period of performance: September 1, 2024 – March 31, 2025 Capability statement /information sought. Companies that believe they possess the capabilities to provide the required services should submit documentation of their ability to meet each of the project requirements to the Contracting Officer. The capability statement must specifically address each of the project requirements separately. Additionally, the capability statement should include 1) the total number of employees, 2) the professional qualifications of personnel as it relates to the requirements outlined, 3) any contractor GSA Schedule contracts and/or other government-wide acquisition contracts (GWACs) by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Capability statements must also include the Company Name, Unique Entity ID from SAM.gov, Physical Address, and Point of Contact Information. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. Interested companies are required to identify their type of business, applicable North American Industry Classification System (NAICS) Code, and size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number. One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing. The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Eric McKay, Contracting Officer, at e-mail address Eric.McKay@nih.gov. The response must be received on or before July 24, 2024, 9:00 am, Eastern Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in www.sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).","origin":"extract"},"notice_type":{"code":"r","label":"Sources Sought"},"schema_version":1,"solicitation_number":"75N95024Q00396","product_service_code":"B537"},{"dates":{"posted":"2024-08-15","response_deadline":{"raw":"2024-08-29T16:00:00-04:00","utc":"2024-08-29T20:00:00Z","date":"2024-08-29","time":"16:00:00","utc_offset_seconds":-14400}},"links":{"sam":"https://sam.gov/workspace/contract/opp/42cc4fe2be2f4310baf8d595025ede3c/view"},"naics":{"codes":["621511"],"primary":"621511"},"title":"Analysis of the cerebral spinal fluid and plasma proteome in Alzheimer’s disease","agency":{"office":{"code":"75N95D","name":"NATIONAL INSTITUTES OF HEALTH NIA"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20852","city":"ROCKVILLE","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-09-13","archive_type":"auto15"},"contacts":[{"name":"ERIC MCKAY","role":"primary","email":"eric.mckay@nih.gov","phone":"3014802406"}],"base_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"notice_id":"42cc4fe2be2f4310baf8d595025ede3c","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"136e806e122a6ca9da5b7be9a81d0897e7d351930f920f630522717d380b1dc2","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"(i) This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95024Q00396 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2024-05, with effective date 5/22/2024. (iv) The associated NAICS code is 621511 and the small business size standard is $41.5 million. This requirement is full and open with no set-aside restrictions. (v) This requirement is for the following services: See “Attachment 1 – Statement of Work” (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance is September 15, 2024 through March 31, 2025. (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.204-29, Federal Acquisition Supply Chain Security Act Orders – Representation and Disclosures (Dec 2023) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services (Nov 2023). HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions below and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Products and Commercial Services (May 2024) FAR 52.222-52 Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014). NIH Invoice and Payment Provisions (viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability (ii) price; (iii) past performance [see FAR 13.106-2(b)(3)] Technical and past performance, when combined, are significantly more important than cost or price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (May 2024), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (x) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 4:00 p.m., Eastern Standard Time, on August 29, 2024, and reference Solicitation Number 75N95024Q00396. Responses must be submitted electronically to Eric McKay, Contracting Officer at eric.mckay@nih.gov. Fax responses will not be accepted.","origin":"extract"},"notice_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"schema_version":1,"solicitation_number":"75N95024Q00396","place_of_performance":{"zip":"21224","city":{"name":"Baltimore"},"state":{"code":"MD"},"country":{"code":"USA"}},"product_service_code":"B537"}],"due_at":"2024-08-29T20:00:00Z","due_date":"2024-08-29","closes_at":"2024-08-29T20:00:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N95D","office_name":"NATIONAL INSTITUTES OF HEALTH NIA","state":"MD","county":"24510","county_name":"City of Baltimore","city":"2404000","city_name":"Baltimore","country":"USA","winner_key":"WM9YMMU3P233","amount":null,"linked_awards":2,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"42cc4fe2be2f4310baf8d595025ede3c","description":{"text":"(i) This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95024Q00396 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2024-05, with effective date 5/22/2024. (iv) The associated NAICS code is 621511 and the small business size standard is $41.5 million. This requirement is full and open with no set-aside restrictions. (v) This requirement is for the following services: See “Attachment 1 – Statement of Work” (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance is September 15, 2024 through March 31, 2025. (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.204-29, Federal Acquisition Supply Chain Security Act Orders – Representation and Disclosures (Dec 2023) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services (Nov 2023). HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions below and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Products and Commercial Services (May 2024) FAR 52.222-52 Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014). NIH Invoice and Payment Provisions (viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability (ii) price; (iii) past performance [see FAR 13.106-2(b)(3)] Technical and past performance, when combined, are significantly more important than cost or price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (May 2024), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (x) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 4:00 p.m., Eastern Standard Time, on August 29, 2024, and reference Solicitation Number 75N95024Q00396. Responses must be submitted electronically to Eric McKay, Contracting Officer at eric.mckay@nih.gov. Fax responses will not be accepted.","html":null,"origin":"extract"},"contacts":[{"name":"ERIC MCKAY","role":"primary","email":"eric.mckay@nih.gov","phone":"3014802406"}],"place_of_performance":{"zip":"21224","city":{"name":"Baltimore"},"state":{"code":"MD"},"country":{"code":"USA"}},"office_address":{"zip":"20852","city":"ROCKVILLE","state":"MD","country":"USA"},"naics_codes":["621511"],"award":null,"attachments":[],"awards":[{"award_key":"CONT_AWD_75N95024P00593_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95024P00593_7529_-NONE-_-NONE-/","piid":"75N95024P00593","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"WM9YMMU3P233","recipient_name":"ALAMAR BIOSCIENCES, INC.","recipient_uei":"WM9YMMU3P233","recipient_cage":"87PS4","recipient_city":"FREMONT","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-09-10","last_action_date":"2025-03-20","actions":2,"obligated":"247000.00","current_total_value":"247000.00","potential_total_value":"247000.00","naics":"621511","psc":"B537","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"NULISASEQ CNS DISEASE PANEL-SERVICES","method":"solicitation","confidence":"high","evidence":["solicitation number 75N95024Q00396 equals the FPDS solicitation identifier","same sub-agency 7529"],"opportunity_key":null,"opportunity_title":null}],"related":[]}